Sexual Health & Medical Wellness Cialis linked to higher glaucoma risk in large study September 26, 2026 Susilo Ahmad The findings, which draw from an extensive analysis of patient health records, suggest that men utilizing tadalafil—a medication belonging to the phosphodiesterase type 5 inhibitor (PDE5i) class—over extended durations for…
Sexual Health & Medical Wellness Long-term use of tadalafil for prostate-related urinary symptoms is associated with an increased risk of glaucoma according to a new clinical study. September 18, 2026 Susilo Ahmad A significant study published in the British Journal of Ophthalmology has brought new attention to the potential ocular side effects of common erectile dysfunction medications when used in a long-term,…
Sexual Health & Medical Wellness Cialis linked to higher glaucoma risk in large study September 10, 2026 Susilo Ahmad The study, which examined health records from nearly 74,000 men, provides new evidence regarding the ocular safety profile of phosphodiesterase type 5 inhibitors (PDE5i). While these medications—most commonly known for…
